RESUMEN
Aerobic exercise, training to sustain motor ability, and respiratory rehabilitation may improve general functioning and quality of life (QoL) in neuromuscular disorders. Patients with late-onset Pompe disease (LOPD) typically show progressive muscle weakness, respiratory dysfunction and minor cardiac involvement. Characteristics and modalities of motor and respiratory rehabilitation in LOPD are not well defined and specific guidelines are lacking. Therefore, we evaluated the role of physical activity, therapeutic exercise, and pulmonary rehabilitation programs in order to promote an appropriate management of motor and respiratory dysfunctions and improve QoL in patients with LOPD. We propose two operational protocols: one for an adapted physical activity (APA) plan and the other for an individual rehabilitation plan, particularly focused on therapeutic exercise (TE) and respiratory rehabilitation.
Asunto(s)
Ejercicios Respiratorios/métodos , Terapia por Ejercicio/métodos , Ejercicio Físico , Enfermedad del Almacenamiento de Glucógeno Tipo II/rehabilitación , Enfermedades Musculares/rehabilitación , Adolescente , Adulto , Edad de Inicio , Ciclismo , Niño , Protocolos Clínicos , Ejercicio Físico/fisiología , Enfermedad del Almacenamiento de Glucógeno Tipo II/complicaciones , Humanos , Ejercicios de Estiramiento Muscular , Enfermedades Musculares/etiología , Entrenamiento de Fuerza/métodosRESUMEN
Nusinsersen is now available in Italy for all SMA types. We describe the experience with intrathecal treatment with nusinersen in 50 patients with SMA at the NEMO Center (NEuroMuscular Omniservice Clinical Center) in Milan, a neuromuscular patient-centered clinic hosted within Niguarda Hospital, a National Public General Hospital. Our results indicate that the pathway of care described outweighs the burden due to the repeated intrathecal injections. Irrespective of age and severity, the treatment is feasible, accessible, and replicable provided that there is a multidisciplinary team having experience and training in SMA.